Navigation Links
PLoS ONE is launched by the Public Library of Science

Until now, online scientific journals have been little more than electronic versions of the printed copy. Today, that all changes with the launch of PLoS ONE, which publishes primary research from all areas of science and employs both pre- and post-publication peer review to maximize the impact of every report it publishes. PLoS ONE is published by the Public Library of Science (PLoS), the open access publisher whose goal is to make the world's scientific and medical literature a public resource.

PLoS has taken a close look at the way scientific and medical publishing works now, and has asked how the Internet can be used to make it work better. As a result, virtually everything about PLoS ONE is new: the peer-review strategy, the production workflow, the author experience, the user interface, and the software that provides the publishing platform.

Harold Varmus, Co-Founder and Chair of the Board of PLoS and President of the Memorial Sloan-Kettering Cancer Center, remarks, "For those of us who have been engaged with PLoS from its conception, the launch of PLoS ONE is tremendously exciting;this is the moment when we seize the full potential of the Internet to make communication of research findings an interactive and fully accessible process that gives greater value to what we do as scientists."

PLoS ONE was first described to the research community back in June 2006, and the response to the proposal has been enthusiastic and sustained. Although PLoS ONE opened its doors to manuscript submissions only in August, it already receives in excess of 100 submissions each month and launches with the publication of 100 peer-reviewed research articles. The volume of articles is unprecedented for a journal launch, and is an indication of the strong support within the research community for the PLoS ONE approach.

The articles published today have been peer-reviewed under the guidance of an extensive academic editorial board, and cover a bro ad range of research topics, from basic molecular science to clinical studies. Specific subjects include the evolution of language1, the control of rabies2, mimicry of jumping spiders3, and Alzheimer's disease4. And because the articles are published under an open access license, these scientific riches are free for everyone to read, reuse, and build upon.

The work published at the launch of PLoS ONE is impressive in its own right, but the power of this project really lies in what happens after publication. In almost all other journals, publication of a research paper is a full stop. The next significant step forward will be the publication of another paper following on from the previous work. But in PLoS ONE, as soon as an article is published, a conversation between authors and readers can begin. There might be a question about a method that is described in the article, a link to another useful work or resource that can be added, or an alternative interpretation that can be offered for some of the results. In each case, readers and authors can respond to the addition, and everyone else can benefit from the resulting dialogue. The possibilities are without limit, and the applications of this technology will no doubt hold some surprises.

The beta version5 of PLoS ONE that is launched today is a work-in-progress. It is presented in beta because PLoS wishes the community to help shape PLoS ONE, and the underlying publishing platform, into its most valuable form. The software is open source6, and will form the first part of an innovative and flexible publishing system that will be developed over the next two years and will be available to all groups for storing, disseminating, and sharing literature and data.

PLoS ONE will accelerate the pace of scientific research because publication is faster and more interactive than ever before. No longer need there be months of delay between submission and publication. Now there is a way to share not only the results of research but also the responses, ideas, and opinions of fellow researchers as well.


'"/>

Source:Public Library of Science


Related biology news :

1. Roche clinical trial registry and results database launched
2. First technology to remove prions that cause vCJD from blood launched
3. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
4. NIH Calls on Scientists to Speed Public Release of Research Publications
5. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
6. Public collections of DNA and RNA sequence reach 100 gigabases
7. Public release of pig genomic sequences
8. Public Library of Science to launch new, open access journal on neglected tropical diseases
9. Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer
10. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
11. Leprosy genome tells story of human migrations, French researchers report in Science
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)... ... October 09, 2017 , ... The ... medical marijuana products targeting the needs of consumers who are incorporating medical marijuana ... place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The ...
Breaking Biology Technology: